Usual therapies against malignant tumors, such as surgery, chemotherapy, radiation, is severe and when repeated their efficiency may decrease because tumorous cells may become resistant. Contrarily, hyperthermia has been known for some time as an effective auxiliary treatment, which can be applied repeatedly. In some cases of abdominal carcinomatosis, particularly those of digestive origin, HIPEC is considered as an promising therapeutic option. Chemotherapy and hyperthermia are combined via the perfusion of the abdominal cavity with hot fluids containing chemotherapeutic agents, thus, augmenting the influence of appropriate chemotherapeutic agents with heat. The paper deals with in vivo temperature measurements during the treatment and the identification and development of a heat transfer model of the treatment and consequently its optimization. First, the focus is on in vivo acquisition and monitoring of temperatures. Temperature probe characteristics are identified. Next, a dynamic model for the heat transfer in the patient's body during the HIPEC is outlined. Then model is validated using experimental data collected by the medical partners (St-Etienne Bellevue and Lyon-Sud, France) during in vivo HIPEC. Finally, the concluding comments are reported, including the current perspectives. Since the effectiveness of HIPEC is based on the achievement of a uniform hyperthermic intracavity temperature, properly modelling and developing supervising/monitoring methods for heat transfer for this procedure is the motivation for this research. The paper presents some preliminary groundwork for an eventual simulator and decision aid related to HIPEC.
Introduction
The effectiveness of hyperthermia or thermotherapy in conjunction with other forms of cancer therapy has recently become well known. Research has demonstrated that high temperatures can injure and kill malignant cells, usually with minimal damage to healthy tissues (Vander Zee 2002) by exterminating cancer cells and damaging proteins and structures within cells (Hilderbrandt and Wust 2002) , hyperthermia may diminish the size of tumors. This thermal chemical saturation of affected tissue allows better penetration the chemotherapeutic agents. In addition, this procedure minimizes deleterious effects of high doses of intravenous chemotherapy.
The synergy of chemo-hyperthermia is even more compelling in the case when administered intraperitoneally for peritoneum carcinomatosis of digestive tract origin since these patients often die within 6 months. With heated or Hyperthermic Chemotherapy (HIPEC) there is a better assimilation of the chemotherapy locally in the peritoneal cavity, where systemic or traditional chemotherapy is known to be ineffective. This procedure, has become a very promising therapeutic option. HIPEC is applied during surgery, via an open or closed abdominal approach, the former in USA (Sugarbeker and Jablonsky 1995; Sugarbeker 1995) , Germany (Jähne et al. 1997) and Japan (Yonemura et al. 1991) and the latter in France (Gilly et al. 1994; Salle et al. 1993; Detroz et al. 1994; Dubé et al. 1997) .
Both have opposing advantages and drawbacks: temperature and drug homogeneity versus patient safety. This paper presents significant research results on the closed-abdomen HIPEC protocol, which seems inherently safer but is more 1 3
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HIPEC is performed after cytoreductiye surgery which removed "visible" tumoral bodies. HIPEC consists of rinsing the abdominal cavity, either left open (USA, Japan,…) or closed and prepared (France and increasingly the USA…), with a hot dialysis liquid at about 42 °C containing anti-cancer drugs such as, for example, Mitomycine C or Cisplatine (direct chemotherapy), Fig. 1 .
Clinical investigations have proven an increased survival rate after surgeries followed by HIPEC (Glehen et al. 2004; Goldstein et al. 2005; Gomez-Portilla et al. 2005; Barkin et al. 2014; Fujimoto et al. 1997) .
The duration of the HIPEC procedure can differ from one medical team to another. On average, the cancer stricken internal organs are bathed in heated chemotherapy for 60-90 min to kill any microscopic cancer cells. HIPEC is carried out under general anaesthesia. The input tubes/catheters and output drains are placed in the peritoneal cavity and are connected to the sterile pumping and heating circuit. HIPEC is performed by circulating a heated liquid using a blood pump which allows to adjust the flow between min and max values (0 to 3.5 L/min). Chemotherapy is added to the circulating hot liquid. Subcutaneous temperature sensors are placed in order to control the heat transfers during the HIPEC. The details of the procedure may differ from one team to another. The input temperature is generally between 46 and 48.7 °C and the intraperitoneal temperatures are targeted at 42 °C so as to avoid necrosing healthy cells while destroying tumoral tissue. As briefly referred to earlier, the principle technical problem of this treatment is the homogenization of the temperatures distribution in the abdominal cavity. In vitro modelling approaches have been carried out and their results described Szafnicki et al. 1998 ). An in vitro mathematical model, based on a prototype of the abdomen, has been proposed so as to represent the thermal aspects of the abdominal cavity and simulation results have been outlined . Many researches focused on studying and controlling the HIPEC's equipment (Ladhari et al. 2005; Lungoci et al. 2015a, b) , others on modelling some aspects of cancer treatment, (Pang et al. 2016; Simbawa 2017) .
In this paper, some aspects of the in vivo temperature measurement and control/supervision are presented. Thermal modelling was developed (Clitan et al. 2015 ) so as to simulate the temperature in the abdominal cavity as close as possible to the real actual conditions during HIPEC.
Methods and materials

Data acquisition and temperature measurements
The real-time monitoring and optimization methodology for in vivo IPHC, as developed in this paper, are based on two main aspects:
• Data acquisition and treatment, • Process modelling, for better understanding and optimization.
These two aspects are detailed as follows:
Data acquisition
Any data acquisition implies sensors connected to the specific acquisition and transmission device(s Bodytherm is a simpler device, enabling an in vivo acquisition and monitoring of up to 10 temperatures. However, it requires a RS232 connection to a laptop-PC and its own software.
Cavitherm, which has been used for HIPEC since 1999, is a more complex device (EFS 2017), Fig. 2 , including up to 8 temperature sensor as well as fluid flow, pressure and volume indicators. Cavitherm also includes a display and control panel. All parameters: pressure, flow, injected quantity and the intervention duration are recorded on a 3″5 diskette and/or via RS232 to a laptop-PC, with a sampling period of 4.07 s. A removable sterile single-use cartridge integrates Table 1 . Therefore, the temperature acquisition device permanently performs the conversion between the measured resistance and the corresponding temperature. Moreover, the temperature measurements are affected by two important characteristics of the sensors and the measuring devices:
• Their resolution and accuracy, • Dynamical (time response) parameters.
Temperature measurements
Dynamic parameters (time constants, delays) of the temperature sensors have been verified during different experiments, either in liquid or gaseous environments. Time constants thus experimentally determined were: τ l ~ 6 s in liquid and τ g ~ 33 s in gas (air). Time delays have been found negligible compared to the estimated time constants. A time constant gives an idea of the rapidity of the convergence of the measured value from the real value, particularly in the case of a step-like variation of the latter, Fig. 3 . It is admitted that the 95% of the final value of a step-response has been reached at 3τ. This applied to the estimated time constant values τ l and τ g gives 18 s and 99 s (= 1 min 39 s) respectively.
Let us stress the considerable slower response time lag if the sensor is operating in gaseous environment. In addition, air bubbles may be present in the abdominal cavity during IPHC. Therefore, it is of vital importance to have the temperature sensors correctly placed within the cavity; to be totally immersed and in contact with the organs which have to be monitored (liver, mesentery,…), since the manufacturer (www.ysite mpera ture.com) has provided the following thermistance sensor characteristics, within the considered temperature domain:
• Resolution: ± 0.1 °C, accuracy: ± 0.2 °C, • Time constant: 6 s, A model of the abdomen is being developed in order to understand the whole process better and to be able to optimize the procedure.
This will enable the simulation of the temperature evolution in the abdominal cavity versus input flow and temperature. Since the geometry of the abdominal cavity is rather complex, the initial modelling started with some simplified assumptions, such as:
• Liquid was likened to water, • Abdominal cavity volume was approximated as a rectangular prism, Fig. 4 , • The output equaled input flow rate (steady state flow, no accumulation).
Variables and parameters for the heat transfer model
Let us now introduce the following variables and parameters, which are used in the proposed model, Table 2 .
Heat transfer modelling
Total enthalpy balance applied to the liquid circulating in the patient's abdomen allows the following equation to be asserted:
with:
Since the considered process concerns heat transfer by forced convection, the following correlation function can then be considered:
with (Welty et al. 2001 ) giving:
The supposed geometrical form of the abdominal cavity (Fig. 4) as well as the nature of the liquid flow (supposed to be laminar) allows the function f giving the Nusselt's number (Bird et al. 2006 ) to be determined:
The liquid flow velocity then is:
The temperature T usually denotes a logarithmic average of T in and T out . In this paper it has been simplified to a weighted mean: The β ∊ [1, 40] parameter is injected into the model to compensate for the assumptions of modelling such as:
• Considering the characteristics of liquid as those of water, • A rough estimation of the heat exchange surface according to the patient's size and to the weight.
Finally, we obtain a no stationary nonlinear model with adaptable parameters.
Heat transfer model identification and optimization
Model identification and optimization will imply finding optimal values for the coefficients (α, β), i.e. such that the temperature estimated with the model (further on noted as T out |M) fits as closely as possible to the measured one Tout. In order to quantify the proximity between the measured and the estimated output temperature values, a quadratic normed criterion is used: C N is a dimensionless value, expressed in %, independent of the number of samples (measured values) N as well as of the Tout signal power (amplitude). It gives a "quantified idea" of the model's precision. Model identification experience shows that models achieving a C N < 10% can be considered as very precise; the average model's range Heat transfer coefficient (idem 7.36) k liq (Wm
Thermal conductivity (idem 0.60)
T(K)
Mean temperature of the liquid within the abdomen
Mean temperature of the patient's body
Output ( for C N is usually above 10% and below 30%. Note: when C N > 30% the estimated model adequacy is considered questionable at best.
Abdominal model identification and optimization
For model optimization purposes, T p has been assimilated to urinary temperature T uri , and input temperature has been approximated by: T in = max(T in1 , T in2 ). Moreover the folowing anatomical parameters values have been chosen: D = 10 cm, L = 50 cm, l = 50 cm. These a priori values are result of an "average" of the observed patients' anatomical parameters. Two weighted coefficients have been considered in the model: α ∈ [0, 1] and β ∈ [0, 40] in order to compensate the differences due to assumptions and modelling errors (exchange surface estimation, assuming that the liquid's characteristics are those of water…).
The coefficient values were determined by trial-anderror during simulations and data according to the actual measurements, Fig. 5 . A grid of C N values has been computed, with β value steps of 5 and α value steps of 0.1. Note: that the optimal valley (talweg) looks parallel to the α-axis and that the biggest C N variations occur along the β axis (close or over 100% in extreme cases). This clearly shows a predominant influence of the β coefficient on the model precision.
Applying the heat transfer model to clinical test data
An example of the simulation of an optimized model of Eq. (12) has been plotted on Fig. 6 , corresponding to optimal values of α opt = 0.7 and β opt = 10. It has been estimated on data recorded during an in vivo HIPEC which occurred on July 1st, 2002, Fig. 6 .
It is notable that the discrepancies between measured and modelled temperatures are relatively small with a criterion C N |min = 8.3% only. In this case the heat exchange could be modeled rather precisely.
This result is rather common for a number of HIPEC data, which confirms that the influence of the β coefficient is predominant, as can also be noted on the optimization grid, Fig. 5 .
Results and discussion
Models have been validated and optimized on data from 164 in vivo IPHCs. The latter have been chosen out of more than patient's data. Thus, only about 40% of the total available data could be thoroughly exploited a posteriori, mainly due to such problems as:
• Corrupted data acquisition files (sensor or data acquisition problems), • Incomplete IPHCs; • Unstable temperature produced by the heat generator (regulation problems), therefore generating input temperature instability.
The results are summed up on Table 3 . It is apparent that two important model optimization zones appear; both with β-values located in the vicinity of 10, respectively gathering 48% (α ∈ [0,1 0,3]) and 34% (α ∈ [0,6 0,9]) of the optimized couples of values.
High values of β (β ≫ 1) can be justified by the simplification hypothesis of the model, fact it indicates that the exchange surface is much bigger than what has been supposed; since it also involves e.g. the internal organs (viscera, liver…) which are supposed to be "rinsed" by the liquid.
• Zone A: 63 occurrences (38.4%) for α ∈ [0.1 0.3] • Zone B: 61 occurrences (37.1%) for α ∈ [0.6 0.9] Note in both cases the barycentre of optimal values of β is close to 10.
More detailed investigations are on their way so as to determine possible correlations between the optimal values (α opt , opt ) and some of the patients' characteristics. Several other temperature probes such as oral and rectal have been used to monitor these medical procedures in US operating rooms… including them for future research. Data from MRI sensing during a heated chemotherapy test in animals for penetration figures etc.
Conclusion
One of the main difficulties that the surgeon has to cope with during closed-abdomen IPHC is how to maintain a uniform temperature of the liquid close to the desired value (about 42 °C) throughout the treatment. For example, a brief analysis of several temperature curves measured in vivo during IPHC has shown that the "Mesentery" temperature was usually unstable and in most cases it did not reach the targeted 42 °C. A better understanding of the heat transfer within the abdomen could lead to a more optimal temperature dispatch. The development of a specific optimization tool as outlined in this paper, will help in the in vivo IPHC optimization task. Future investigations should be concerned with the determination and identification of possible correlations between the estimated optimal coefficients (α opt , β opt ) and some of the patients' characteristics. Indeed, we can use the patient's height, weight, corporal surface. Also the type and extent of the previous surgical intervention(s), as well as the intermediary temperatures modeling (e.g. mesentery). In order to be statistically relevant, research must treat data of larger number of patients.
Thus a validated IPHC model, being able to estimate various temperature values in real-time (or: anticipate events before they occur) will help to establish a reliable, realtime (on-line) supervision and optimization methodology for in vivo IPHC. This developed model must be based on thermal knowledge as well as on anatomical characteristics of the patients. It can therefore be qualified as a knowledge model rather than a behaviour model, which offers a wide scope of possible future adaptations to the particular patient characteristics.
